Why the study?
Heart failure poses a global challenge with traditional management contributing to high readmission and mortality rates, prompting evaluation of autonomous peripheral oedema monitoring.
Does the Heartfelt device improve the prediction of heart failure decompensation compared to traditional weighing in patients with heart failure?
Population
31 patients enrolled across five UK NHS trusts
Comparison
Heartfelt remote peripheral oedema monitoring vs traditional weighing (standard care)
Design
Multicentre observational study
Key result
The Heartfelt remote monitoring device predicted heart failure decompensation with a 13-day lead time, providing more consistent and frequent data than traditional weighing methods.
Authors
Loading...
May facilitate earlier HF intervention than daily weights; extends remote monitoring evidence but leaves open impact on outcomes.
Does the Heartfelt device improve the prediction of heart failure decompensation compared to traditional weighing in patients with heart failure?
The Heartfelt device provides continuous remote monitoring of peripheral edema, potentially allowing for earlier detection of heart failure decompensation with a 13-day lead time compared to standard care.
Dewhurst et al. (2026) studied this question. The Heartfelt remote monitoring device predicted heart failure decompensation with a 13-day lead time, providing more consistent and frequent data than traditional weighing methods.